Mumbai, Aug 23 (TIWN) Corporate earnings for April-June were robust despite the second wave of Covid-19 and a report by ICICI Direct Research showed that the topline growth during the quarter was led by pharmaceutical companies.

Corporate earnings for April-June were robust despite the second wave of COVID-19 and a report by ICICI Direct Research showed that the topline growth during the quarter was led by pharmaceutical companies.